Opsens Solutions will be present at EPE’ 23 ECCE Europe
31 August 2023Opsens Solutions will be present at EPE’ 23 ECCE Europe, in Aalborg, Denmark, September 4-8, 2023. For more information, please contact us at .
The new generation of signal conditioner is here
27 April 2023The latest signal conditioner is available in single channel for both technologies supported by Opsens Solutions. The HandySensG for temperature measurement using GaAs technology, and the HandySensW for WLPI type sensors. Compact and portable, it has an autonomy of 8 hours thanks to its rechargeable battery. Its rugged design allows it to be used in…
Opsens Solutions will be exhibiting at the leading international symposium PCIM on power electronic in May 9-11, Nuremberg, Germany
24 April 2023Come and see the new developments related to power electronics instrumentation at the booth 410, Hall 9. A joint paper with Aalborg University will be also presented during the conference.
Opsens Solutions will be present at the 15th China International Nuclear Energy Industry Exhibition (CIENPI) in Beijing, from April 26 to 28, 2023.
14 April 2023New advances related to instrumentation in radioactive environments and nuclear energy will be presented by Opsens Solutions’ partner in China, Opsensing at booth E32
Opsens Solutions is hosting an advanced workshop for HERO testing on the 20th and 21st of June 2023 in Annecy, France
8 March 2023The workshop is dedicated to RadSens users in order to improve the EID instrumentation process and to optimize the critical steps related to HERO testing. The two-day session will be held at the Novotel in downtown Annecy. The hotel is easily accessible from Geneva International Airport by car (30 minutes) or direct train (90 minutes)…
Opsens Solutions will be present at InterBattery 2023, in Seoul, Korea March 15-17
6 March 2023Part of a Canadian delegation, this conference will allow the presentation of new sensors related to the battery industry. For more information, please contact us at
OpSens Announces FDA Clearance for the SavvyWire™ for Use in Transcatheter Aortic Valve Replacement (TAVR) Procedures
15 September 2022OpSens Announces FDA Clearance for the SavvyWire™ for Use in Transcatheter Aortic Valve Replacement (TAVR) Procedures Quebec City, Quebec, September 15, 2022 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that it has received 510(k) regulatory clearance from…
Opsens Solutions will be present at ESREF 2022, in Berlin (Germany) from September 26-29, 2022
9 September 2022Opsens Solutions will be present at ESREF 2022, in Berlin (Germany) from September 26-29, 2022 at the H4 Hotel Berlin Alexanderplatz, Please come to visit us at booth 2.
OpSens to Host Third Quarter Fiscal Year 2022 Financial Results Conference Call on Thursday, July 14
7 July 2022OPSENS TO HOST THIRD QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, JULY 14 Conference call to be conducted at 11:00 am ET Quebec City, Quebec, July 7, 2022 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, will…
OpSens Announces Second Quarter Fiscal 2022 Financial Results
13 April 2022OpSens Announces Second Quarter Fiscal 2022 Financial Results Conference call will be held today at 11:00 a.m. ET Quebec City, Quebec, April 13, 2022 – OpSens Inc. (“OpSens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today released results for its…